Get the Stockscreener App
3.14
0.32%
0.01
After Hours:
3.15
0.010
+0.32%
Accendra Health Inc stock is traded at $3.14, with a volume of 343.51K.
It is up +0.32% in the last 24 hours and down -1.88% over the past month.
Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.
See More
Previous Close:
$3.13
Open:
$3.11
24h Volume:
343.51K
Relative Volume:
0.46
Market Cap:
$240.47M
Revenue:
$4.72B
Net Income/Loss:
$-123.85M
P/E Ratio:
-0.2196
EPS:
-14.2981
Net Cash Flow:
$-303.12M
1W Performance:
-9.51%
1M Performance:
-1.88%
6M Performance:
+48.82%
1Y Performance:
-82.02%
1-Day Range:
$3.0501
$3.165
1-Week Range:
$2.97
$3.535
52-Week Range:
$1.885
$4.6887
Accendra Health Inc Stock (ACH) Company Profile
Name
Accendra Health Inc
Sector
Industry
Phone
(804) 277-4304
Address
4435 WATERFRONT DRIVE, GLEN ALLEN
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACH
Accendra Health Inc
|
3.14 | 240.47M | 4.72B | -123.85M | -303.12M | -14.30 |
MCK
Mckesson Corp
|
840.90 | 98.45B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
309.89 | 60.29B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
228.03 | 53.41B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
85.47 | 9.74B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.51 | 1.29B | 14.85M | -136.07M | 7.25M | -0.4726 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-03-25 | Downgrade | UBS | Buy → Neutral |
| Jul-19-24 | Upgrade | Citigroup | Neutral → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Downgrade | Citigroup | Buy → Neutral |
| Oct-12-22 | Downgrade | BofA Securities | Buy → Underperform |
| Oct-12-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-26-22 | Resumed | Citigroup | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Neutral |
| Mar-30-22 | Resumed | JP Morgan | Underweight |
| Mar-23-22 | Upgrade | HSBC Securities | Reduce → Hold |
| Apr-08-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-08-21 | Upgrade | Goldman | Sell → Buy |
| Dec-17-20 | Upgrade | UBS | Neutral → Buy |
| Sep-25-20 | Upgrade | Barclays | Underweight → Equal Weight |
| Jul-21-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jul-14-20 | Upgrade | Credit Suisse | Neutral → Outperform |
| May-05-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Apr-23-20 | Resumed | Credit Suisse | Neutral |
| Jan-21-20 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Jan-07-20 | Downgrade | Goldman | Neutral → Sell |
| Nov-15-19 | Upgrade | CLSA | Underperform → Outperform |
| Sep-06-19 | Reiterated | BofA/Merrill | Neutral |
| Apr-10-19 | Reiterated | BofA/Merrill | Neutral |
| Apr-03-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Apr-01-19 | Upgrade | JP Morgan | Underweight → Overweight |
| Jan-18-19 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Neutral |
| Jan-15-19 | Upgrade | CLSA | Underperform → Outperform |
| Dec-14-18 | Downgrade | Morgan Stanley | Overweight → Underweight |
| Dec-12-18 | Downgrade | Goldman | Buy → Neutral |
| Sep-28-18 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-11-18 | Downgrade | CLSA | Outperform → Sell |
| Apr-10-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Mar-26-18 | Upgrade | Goldman | Sell → Neutral |
| Nov-02-17 | Downgrade | HSBC Securities | Buy → Hold |
| Mar-24-16 | Upgrade | Goldman | Sell → Neutral |
| Dec-07-15 | Downgrade | Goldman | Neutral → Sell |
| Aug-31-15 | Upgrade | Credit Suisse | Underperform → Neutral |
| Aug-01-12 | Initiated | HSBC Securities | Underweight |
| Aug-05-09 | Upgrade | Citigroup | Sell → Buy |
| Dec-01-08 | Downgrade | HSBC Securities | Neutral → Underweight |
View All
Accendra Health Inc Stock (ACH) Latest News
Paradigm Capital Management Inc. NY Purchases New Position in Accendra Health, Inc. $ACH - MarketBeat
Accendra Health Inc Revenue Breakdown – MUN:6OM - TradingView
Accendra Health (ACH) Q2 2024 earnings summary - Quartr
Enterprise value to EBIT forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Enterprise value to EBIT forward of Accendra Health Inc – GETTEX:6OM - TradingView
Accendra Health files prospectus for $200M mixed shelf - scanx.trade
Accendra Health Files $200 Million Mixed Shelf Registration - Moomoo
Form S-3 Accendra Health Inc For: 15 July By Investing.com - Investing.com Nigeria
Price to earnings forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Accendra Health Inc. (ACH) Surges 7.27%: Bullish Momentum Tests Key ResistanceFundamental Weighted - dars.gov.et
Accendra Health (ACH) Has Home-Care Scale, but the Debt Stack Drives the Risk - AlphaStreet
Price to earnings forward of Accendra Health Inc – SWB:6OM - TradingView
Enterprise value to revenue forward of Accendra Health Inc – SWB:6OM - TradingView
Price to sales forward of Accendra Health, Inc. – NYSE:ACH - TradingView
Accendra Health Concludes Exchange Offers for Senior Notes Due 2029 and 2030 - sekbernews.id
Accendra Health (ACH) is One of The 15 Best NYSE Penny Stocks According to Hedge Funds - Yahoo Finance
Price to sales forward of Accendra Health Inc – SWB:6OM - TradingView
Accendra Health (ACH) Sheds 1.5% as Shares Approach Key Support ZoneLow Volume Node - dars.gov.et
Is the Options Market Predicting a Spike in Accendra Health Stock? - MSN
ACH Q1 2026 Earnings: EPS Beat Surprises Market, Stock Jumps 4.68%Dividend Cut Risk - dars.gov.et
Accendra Health Inc. Q1 2026 Earnings: EPS Beats Estimates but Stock DeclinesStrong Earnings Momentum - dars.gov.et
Accendra Health Inc. (ACH) Slides Slightly as Shares Test Support Near $3.14Donchian Channel - dars.gov.et
Accendra Health, Inc.(NYSE: ACH) added to Russell Microcap Value Benchmark Index - marketscreener.com
Accendra Health, Inc.(NYSE: ACH) added to Russell 3000E Index - marketscreener.com
Accendra Health Inc Actuals & Estimates (NYSE:ACH) - TradingView
ACHAccendra Health Inc Options - Finviz
Accendra Health, Inc.(NYSE: ACH) added to Russell 3000E Value Benchmark - marketscreener.com
Accendra Health Completes Major Exchange Offer, Restructures Debt - TipRanks
Accendra Health reports near-complete tenders in exchange offers, issues new secured notes - TradingView
ACH Forecast — Price Target — Prediction for 2027 - TradingView
Accendra Health Reports Expiration of Exchange Offers, Final Tender Results - Moomoo
Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations - Business Wire
ACH Q1 2026 Earnings: EPS Beat Drives Positive Market Response Despite Revenue UncertaintyEPS Estimate Trend - dars.gov.et
ACH News | ACCENDRA HEALTH INC (NYSE:ACH) - ChartMill
Accendra Health Ord Shs (ACH) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Accendra Health Inc. (ACH) Q1 2026 Earnings: Strong EPS Beat Signals Operational ImprovementFiscal Year Earnings - dars.gov.et
Accendra Health Announces Early Results of Exchange Offers and Consent Solicitations for Senior Notes - Minichart
Accendra Health Completes Major Debt Exchange and Refinancing - TipRanks
Accendra Health (ACH) price target increased by 28.92% to 4.27 - MSN
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Surprises to the Upside Despite No Revenue DisclosureEarnings Per Share - newsline.com
Accendra Health receives 99% participation in debt exchange offer - Investing.com UK
Accendra Health receives 99% participation in debt exchange offer By Investing.com - Investing.com Australia
Accendra Health Announces Early Results of Offers and Consent Solicitations - Business Wire
Accendra Health secures 99% participation in exchange offers - scanx.trade
Accendra Health (ACH) Gains 4.71% as Momentum Builds Toward Key Resistance ZoneStock Surge Alerts - dars.gov.et
Are Options Traders Betting on a Big Move in Accendra Health Stock? - MSN
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Beats by 60.9% but Stock Declines on Revenue UncertaintyReturn On Equity - dars.gov.et
Accendra Health (ACH) Q4 2025 earnings summary - Quartr
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Beats Estimates by 60.9% as Loss Narrows to $0.04 Per ShareConsensus Forecast Report - newsline.com
Accendra Health Inc. (ACH) Q1 2026 Earnings: EPS Beats Estimates with a 60.9% Surprise as Narrower Loss Fuels Investor OptimismEarnings Call Highlights - dars.gov.et
Accendra Health Inc Stock (ACH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Accendra Health Inc Stock (ACH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Coliseum Capital Management, L | 10% Owner |
Aug 14 '25 |
Buy |
5.31 |
492,852 |
2,617,044 |
13,100,807 |
| Coliseum Capital Management, L | 10% Owner |
Aug 13 '25 |
Buy |
5.46 |
325,000 |
1,774,500 |
12,607,955 |
0.99%
0.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):